Integrated Wealth Management (Palm Desert)’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-12
Closed 1236
2016
Q3
$0 Hold
12
﹤0.01% 1365
2016
Q2
$0 Hold
12
﹤0.01% 1419
2016
Q1
$0 Hold
12
﹤0.01% 1386
2015
Q4
$0 Hold
12
﹤0.01% 1437
2015
Q3
$0 Hold
12
﹤0.01% 1435
2015
Q2
$0 Hold
12
﹤0.01% 1538
2015
Q1
$0 Buy
+12
New +$305 ﹤0.01% 1413

Integrated Wealth Management (Palm Desert)'s AEGR Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 12 shares.

Integrated Wealth Management (Palm Desert) first reported a position in AEGR in Q1 2015 and held it in 7 quarters. The position peaked at $0 in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 12 Aegerion Pharmaceuticals shares in Q4 2016.
  • Integrated Wealth Management (Palm Desert) first reported a position in Aegerion Pharmaceuticals in Q1 2015 and held it in 7 quarters.
  • Integrated Wealth Management (Palm Desert)'s Aegerion Pharmaceuticals position peaked at $0 in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.